No Overall Damage Progression Despite Persistent Inflammation in Adalimumab-Treated Psoriatic Arthritis Patients: Results from an Investigator Initiated 48-week Comparative Magnetic Resonance Imaging, Computed Tomography and Radiography Trial

No Overall Damage Progression Despite Persistent Inflammation in Adalimumab-Treated Psoriatic Arthritis Patients: Results from an Investigator Initiated 48-week Comparative Magnetic Resonance Imaging, Computed Tomography and Radiography Trial

Read the publication >

Publications

No Overall Damage Progression Despite Persistent Inflammation in Adalimumab-Treated Psoriatic Arthritis Patients: Results from an Investigator Initiated 48-week Comparative Magnetic Resonance Imaging, Computed Tomography and Radiography Trial

Maecenas tempor, ex at maximus efficitur, felis sem ultrices ligula, ut hendrerit purus eros ac urna. Vestibulum ut vestibulum tortor. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cras eu lectus quam. Nunc ligula arcu, auctor sit amet tellus eleifend, facilisis laoreet odio. Donec placerat urna eleifend blandit porttitor.

Nunc magna turpis, tristique at dictum vel, sollicitudin blandit felis. Morbi aliquam elit et pellentesque vulputate. Donec elementum, ante quis ornare porttitor, tortor dolor vestibulum velit, et viverra enim massa vitae ex.

Contact Us

Phone Icon

T: +44 7413 022053

Email Icon

E: contact@ia-grp.com

Address Icon

8thFloor, 1 Butterwick, Hammersmith, London, W6 8DL United Kingdom

or

100 E Penn Square, Suite 423 The Wanamaker Building Philadelphia, PA 19107, USA